0001209191-18-014826.txt : 20180301 0001209191-18-014826.hdr.sgml : 20180301 20180301121441 ACCESSION NUMBER: 0001209191-18-014826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180228 FILED AS OF DATE: 20180301 DATE AS OF CHANGE: 20180301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KING RICHARD CENTRAL INDEX KEY: 0001013702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 18655570 MAIL ADDRESS: STREET 1: C/O KOS PHARMACEUTICALS INC STREET 2: 1001 BRICKELL AVE 25TH FL CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-28 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001013702 KING RICHARD C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 0 1 0 0 Chief Operating Officer Common Stock 2018-02-28 4 A 0 10000 25.07 A 39661 D The shares were purchased at prices ranging from $25.05 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. Includes 1,536 shares purchased on 11/30/17 through the issuer's employee stock purchase plan. /s/ Jennifer Rhodes, Attorney-in-fact 2018-03-01